ELIGARD Side Effects

6940127-3 | Depression, Mania, Paranoia
on Aug 19, 2010 Male patient from UNITED STATES , 53 years of age, weighting 177.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), mania, paranoia. Eligard dosage: . During the same period patient was treated with CASODEX (View Casodex Review and Casodex Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

6913508-1 | Osteoporosis
Patient was taking Eligard (View Usage). Patient had the following side effects: osteoporosis (What is osteoporosis?) on Jul 29, 2010 from PORTUGAL Additional patient health information: Male patient , 80 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: . Patient was hospitalized.

6764643-2 | Excessive Granulation Tissue, Foreign Body, Hypersensitivity, Impaired Healing, Injection Site Discharge, Injection Site Erythema, Injection Site Infection, Injection Site Mass, Injection Site Reaction
Adverse event was reported on May 28, 2010 by a Male patient taking Eligard (View Usage) (Dosage: Dose Text: 45 Mg Every Six Monthsunit Dose: 45 Mg) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 68 years of age, weighting 241.4 lb, After Eligard was administered, patient had the following side effects: excessive granulation tissue, foreign body, hypersensitivity, impaired healing, injection site discharge, injection site erythema, injection site infection, injection site mass, injection site reaction. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

6716133-0 | Blood Glucose Increased
on May 06, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Eligard dosage: 7.5mg Qmonth Subq Approx 11/30/09-present.


6699206-0 | Back Pain, Compression Fracture, Osteoporosis
on Apr 19, 2010 Male patient from UNITED STATES , 73 years of age, weighting 200.0 lb, was diagnosed with radical prostatectomy, prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient had the following side effects: back pain (What is back pain?), compression fracture, osteoporosis (What is osteoporosis?). Eligard dosage: .

6682421-X | Injection Site Necrosis, Injection Site Reaction, Product Quality Issue, Prostatic Specific Antigen Abnormal
Patient was taking Eligard (View Usage). After Eligard was administered, patient had the following side effects: injection site necrosis, injection site reaction, product quality issue, prostatic specific antigen abnormal on Apr 06, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: .

6663648-X | Abnormal Behaviour, Aggression, Agitation, Compulsive Shopping, Insomnia, Logorrhoea, Persecutory Delusion, Pressure Of Speech
Adverse event was reported on Mar 31, 2010 by a Male patient taking Eligard (View Usage) (Dosage: 45 Mg Once Every 6 Month Sq) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 65 years of age, weighting 160.0 lb, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, agitation, compulsive shopping, insomnia, logorrhoea, persecutory delusion, pressure of speech. Patient was hospitalized.

6644884-5 | Back Pain, Compression Fracture, Osteoporosis
on Mar 12, 2010 Male patient from UNITED STATES , 72 years of age, was diagnosed with radical prostatectomy and was treated with Eligard (View Usage). Patient had the following side effects: back pain (What is back pain?), compression fracture, osteoporosis (What is osteoporosis?). Eligard dosage: . During the same period patient was treated with TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), FELDENE (View Feldene Review and Feldene Label ).

6612367-4 | Dyspnoea, Fatigue, Thrombophlebitis
on Feb 18, 2010 Male patient from FRANCE , 82 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: dyspnoea, fatigue, thrombophlebitis. Eligard dosage: . During the same period patient was treated with ANDROCUR (View Androcur Review and Androcur Label ). Patient was hospitalized.

6606417-9 | Excessive Granulation Tissue, Foreign Body, Hypersensitivity, Impaired Healing, Injection Site Discharge, Injection Site Erythema, Injection Site Infection, Injection Site Mass, Injection Site Reaction
Patient was taking Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: excessive granulation tissue, foreign body, hypersensitivity, impaired healing, injection site discharge, injection site erythema, injection site infection, injection site mass, injection site reaction on Feb 16, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 241.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: Dose Text: 45 Mg Every Six Monthsunit Dose: 45 Mg. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

6568891-6 | Bone Pain, Joint Destruction
Adverse event was reported on Jan 22, 2010 by a Male patient taking Eligard (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: SWEDEN , 59 years of age, Patient had the following side effects: bone pain, joint destruction. During the same period patient was treated with MACROGOL (View Macrogol Review and Macrogol Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), GOSERELIN ACETATE (View Goserelin Acetate Review and Goserelin Acetate Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ENOXAPARIN SODIUM (Dose:100 Milligram(s)/millilitre) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ). Patient was hospitalized.

6554779-3 | Metastases To Central Nervous System, Pain
on Jan 14, 2010 Male patient from SWEDEN , 65 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: metastases to central nervous system, pain (What is pain?). Eligard dosage: . During the same period patient was treated with BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ), OMEPRAZOLE SODIUM (View Omeprazole Sodium Review and Omeprazole Sodium Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ).

6550902-5 | Excessive Granulation Tissue, Foreign Body, Impaired Healing, Injection Site Discharge, Injection Site Erythema, Injection Site Infection, Injection Site Mass, Injection Site Reaction, Pain
on Jan 19, 2010 Male patient from UNITED STATES , 68 years of age, weighting 241.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: excessive granulation tissue, foreign body, impaired healing, injection site discharge, injection site erythema, injection site infection, injection site mass, injection site reaction, pain (What is pain?). Eligard dosage: Dose Text: 45 Mg Every Six Monthsunit Dose: 45 Mg. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ).

6537690-3 | Metastases To Central Nervous System, Prostate Cancer Metastatic
Patient was taking Eligard (View Usage). Patient had the following side effects: metastases to central nervous system, prostate cancer metastatic on Jan 04, 2010 from SWEDEN Additional patient health information: Male patient , 65 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: . During the same period patient was treated with BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ), OMEPRAZOLE SODIUM (View Omeprazole Sodium Review and Omeprazole Sodium Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ).

6528950-0 | Metastases To Central Nervous System
Adverse event was reported on Dec 16, 2009 by a Male patient taking Eligard (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: SWEDEN , 65 years of age, After Eligard was administered, patient had the following side effects: metastases to central nervous system.

6528934-2 | Injection Site Necrosis, Injection Site Reaction, Prostatic Specific Antigen Abnormal
on Dec 21, 2009 Male patient from UNITED STATES , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: injection site necrosis, injection site reaction, prostatic specific antigen abnormal. Eligard dosage: .

6516895-1 | Myocardial Infarction
on Dec 15, 2009 Male patient from GERMANY , 83 years of age, was diagnosed with diabetes mellitus, prostate cancer (What is prostate cancer?), prophylaxis, hypertension and was treated with Eligard (View Usage). Patient had the following side effects: myocardial infarction. Eligard dosage: . During the same period patient was treated with BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PENTAERITHRITYL TETRANITRATE (View Pentaerithrityl Tetranitrate Review and Pentaerithrityl Tetranitrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), INSULIN (View Insulin Review and Insulin Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), EPOETIN NOS (View Epoetin Nos Review and Epoetin Nos Label ). Patient was hospitalized.

6392480-X | Cerebrovascular Accident, Multi-organ Failure, Prostate Cancer Metastatic
Patient was taking Eligard (View Usage). After Eligard was administered, patient had the following side effects: cerebrovascular accident, multi-organ failure, prostate cancer metastatic on Oct 05, 2009 from GERMANY Additional patient health information: Male patient , 71 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: 22.5 Mg.

6360483-7 | Cerebrovascular Accident, Multi-organ Failure, Prostate Cancer Metastatic
Adverse event was reported on Sep 11, 2009 by a Male patient taking Eligard (View Usage) (Dosage: 22.5 Mg) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , 71 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, multi-organ failure, prostate cancer metastatic.

6280047-3 |
on Jul 20, 2009 Male patient from FRANCE , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). . Eligard dosage: Once Every 6 Months 45 Mg.

6167469-6 | Oedema Peripheral
on Apr 17, 2009 Male patient from SPAIN , 80 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: oedema peripheral. Eligard dosage: Once Every 6 Months 45 Mg.

6147642-3 | Dehydration, Headache, Nausea, Throat Irritation, Weight Decreased
Patient was taking Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, headache (What is headache?), nausea (What is nausea?), throat irritation, weight decreased on Mar 31, 2009 from UNITED STATES Additional patient health information: Male patient , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: . Patient was hospitalized.

6091158-X | Prostatic Specific Antigen Increased
Adverse event was reported on Feb 23, 2009 by a Male patient taking Eligard (View Usage) (Dosage: 4month) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 72 years of age, weighting 173.0 lb, Patient had the following side effects: prostatic specific antigen increased.

6083678-9 | Fatigue, Headache, Lethargy, Nausea, Pituitary Haemorrhage, Visual Impairment
on Jul 07, 2008 Male patient from UNITED STATES , 82 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: fatigue, headache (What is headache?), lethargy, nausea (What is nausea?), pituitary haemorrhage, visual impairment. Eligard dosage: 45 Mg Once - Subcutaneous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TERAZOSIN HYDROCHLORIDE (View Terazosin Hydrochloride Review and Terazosin Hydrochloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6061708-8 | Anxiety, Depression, Suicide Attempt
on Jan 22, 2009 Male patient from UNITED STATES , 61 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), depression (What is depression?), suicide attempt. Eligard dosage: 45 Mg Every 6 Months. During the same period patient was treated with DIOVAN (Unk) (View Diovan Review and Diovan Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), AMBIEN (Unk) (View Ambien Review and Ambien Label ).

5918458-5 | Depression, Suicidal Ideation
Patient was taking Eligard (View Usage). Patient had the following side effects: depression (What is depression?), suicidal ideation on Oct 06, 2008 from FRANCE Additional patient health information: Male patient , 80 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: 45 Mg Oncer Per 6 Months.

5828746-9 | Eye Haemorrhage, Ocular Hyperaemia
Adverse event was reported on Jul 25, 2008 by a Male patient taking Eligard (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , weighting 225.1 lb, After Eligard was administered, patient had the following side effects: eye haemorrhage, ocular hyperaemia.

5675605-0 | Asthenia, Bedridden, Fall, Mobility Decreased, Muscle Disorder, Respiratory Disorder
on Mar 12, 2008 Male patient from UNITED STATES , weighting 139.1 lb, was diagnosed with prostate cancer (What is prostate cancer?), depression (What is depression?), cardiac failure congestive and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bedridden, fall (What is fall?), mobility decreased, muscle disorder (What is muscle disorder?), respiratory disorder. Eligard dosage: 30 Mg Every Three Months. During the same period patient was treated with ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), MIRALAX (Unk) (View Miralax Review and Miralax Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ), M.V.I. (Unk) (View M.v.i. Review and M.v.i. Label ), COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ).

5661852-0 | Transient Ischaemic Attack
on Mar 04, 2008 Male patient from CANADA , 69 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient had the following side effects: transient ischaemic attack. Eligard dosage: .

5637822-5 | Headache, Hypertension
Patient was taking Eligard (View Usage). After Eligard was administered, patient had the following side effects: headache (What is headache?), hypertension on Feb 22, 2008 from CANADA Additional patient health information: Male patient , 71 years of age, . Eligard dosage: . Patient was hospitalized.

5624927-8 | Asthenia, Bedridden, Fall, Mobility Decreased, Muscle Disorder, Respiratory Disorder
Adverse event was reported on Feb 04, 2008 by a Male patient taking Eligard (View Usage) (Dosage: 30 Mg Every Three Months) was diagnosed with prostate cancer (What is prostate cancer?), depression (What is depression?), cardiac failure congestive and. Location: UNITED STATES , weighting 139.1 lb, Patient experienced the following unwanted or unexpected effects: asthenia, bedridden, fall (What is fall?), mobility decreased, muscle disorder (What is muscle disorder?), respiratory disorder. During the same period patient was treated with ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), MIRALAX (Unk) (View Miralax Review and Miralax Label ), VITAMIN D (Unk) (View Vitamin D Review and Vitamin D Label ), M.V.I. (Unk) (View M.v.i. Review and M.v.i. Label ), COUMADIN (Unk) (View Coumadin Review and Coumadin Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ).

5609408-X | Hot Flush, Hypoaesthesia, Loss Of Control Of Legs
on Jan 23, 2008 Male patient from GERMANY , 73 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Eligard (View Usage). Patient had the following side effects: hot flush, hypoaesthesia, loss of control of legs. Eligard dosage: Unk. Patient was hospitalized.

5503090-8 | Idiopathic Thrombocytopenic Purpura
on Oct 22, 2007 Male patient from UNITED STATES , weighting 179.9 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: idiopathic thrombocytopenic purpura. Eligard dosage: 6-month Injection. During the same period patient was treated with PREDNISONE (4-10 Mg Tablets Daily With Breakfast (varied As Directed)) (View Prednisone Review and Prednisone Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), NEXIUM (View Nexium Review and Nexium Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ). Patient was hospitalized.

5485838-4 | Idiopathic Thrombocytopenic Purpura
Patient was taking Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura on Oct 04, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 179.9 lb, was diagnosed with prostatic specific antigen increased and. Eligard dosage: 6-month Injection. During the same period patient was treated with PREDNISONE (4-10 Mg Tablets Daily With Breakfast (varied As Directed)) (View Prednisone Review and Prednisone Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), NEXIUM (View Nexium Review and Nexium Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5397936-4 | Bone Pain, Joint Swelling, Libido Decreased, Oedema Peripheral, Weight Increased
Adverse event was reported on Jul 17, 2007 by a Male patient taking Eligard (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , weighting 265.0 lb, Patient had the following side effects: bone pain, joint swelling, libido decreased, oedema peripheral, weight increased. During the same period patient was treated with SULINDAC (Unk) (View Sulindac Review and Sulindac Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), GABAPENTIN (Unk) (View Gabapentin Review and Gabapentin Label ), FLOMAX (Unk) (View Flomax Review and Flomax Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

5391384-9 | Bone Pain, Joint Swelling, Libido Decreased, Oedema Peripheral
on Jul 10, 2007 Male patient from UNITED STATES , weighting 265.0 lb, was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: bone pain, joint swelling, libido decreased, oedema peripheral. Eligard dosage: . Patient was hospitalized.

5346209-4 | Aphasia, Cerebrovascular Accident, Hemiparesis
on May 28, 2007 Male patient from CANADA , 62 years of age, was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cerebrovascular accident, hemiparesis. Eligard dosage: . Patient was hospitalized.

5335355-7 | Muscular Weakness
Patient was taking Eligard (View Usage). Patient had the following side effects: muscular weakness on Jan 22, 2007 from UNITED STATES Additional patient health information: Male patient , 76 years of age, . Eligard dosage: 7.5 Mg Once - Subcutaneous.

5311109-2 | Blood Pressure Increased, Retinal Detachment
Adverse event was reported on Apr 23, 2007 by a Male patient taking Eligard (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: AUSTRALIA , 59 years of age, After Eligard was administered, patient had the following side effects: blood pressure increased, retinal detachment. Patient was hospitalized.

5298060-1 | Blood Pressure Increased, Retinal Detachment
on Apr 10, 2007 Male patient from AUSTRALIA , 59 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, retinal detachment. Eligard dosage: . Patient was hospitalized.

5075419-9 | Iiird Nerve Paralysis, Pituitary Haemorrhage
on Jul 25, 2005 Male patient from UNITED STATES , 61 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient had the following side effects: iiird nerve paralysis, pituitary haemorrhage. Eligard dosage: . Patient was hospitalized.

5072723-5 | Pituitary Haemorrhage
Patient was taking Eligard (View Usage). After Eligard was administered, patient had the following side effects: pituitary haemorrhage on Jul 28, 2005 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: . Patient was hospitalized.

5053495-7 | Blood Alkaline Phosphatase Increased, Metastases To Bone, Prostatic Specific Antigen Increased
Adverse event was reported on Jun 29, 2006 by a Male patient taking Eligard (View Usage) (Dosage: ) . Location: UNITED STATES , 73 years of age, Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, metastases to bone, prostatic specific antigen increased.

5048268-5 | Blood Alkaline Phosphatase Increased, Metastases To Bone, Prostatic Specific Antigen Increased
on Jun 29, 2006 Male patient from UNITED STATES , 73 years of age, was treated with Eligard (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, metastases to bone, prostatic specific antigen increased. Eligard dosage: .

4959269-7 | Diabetes Mellitus, Insulin Resistance
on Feb 28, 2006 Male patient from CANADA , 66 years of age, weighting 215.4 lb, was diagnosed with prostate cancer metastatic and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: diabetes mellitus, insulin resistance. Eligard dosage: . During the same period patient was treated with BICALUTAMIDE (Unk) (View Bicalutamide Review and Bicalutamide Label ), FLUTAMIDE (Unk) (View Flutamide Review and Flutamide Label ).

4947163-7 | Diabetes Mellitus
Patient was taking Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus on Feb 28, 2006 from CANADA Additional patient health information: Male patient , 66 years of age, weighting 215.4 lb, was diagnosed with prostate cancer metastatic and. Eligard dosage: . During the same period patient was treated with BICALUTAMIDE (Unk) (View Bicalutamide Review and Bicalutamide Label ), FLUTAMIDE (Unk) (View Flutamide Review and Flutamide Label ).

4937037-X | Diabetes Mellitus
Adverse event was reported on Feb 28, 2006 by a Male patient taking Eligard (View Usage) (Dosage: ) was diagnosed with prostate cancer metastatic and. Location: UNITED STATES , 66 years of age, weighting 215.4 lb, Patient had the following side effects: diabetes mellitus. During the same period patient was treated with BICALUTAMIDE (Unk) (View Bicalutamide Review and Bicalutamide Label ), FLUTAMIDE (Unk) (View Flutamide Review and Flutamide Label ).

4908907-3 | Injection Site Extravasation, Injection Site Necrosis, Injection Site Reaction, Skin Disorder, Skin Reaction
on Jan 12, 2006 Male patient from CANADA , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). After Eligard was administered, patient had the following side effects: injection site extravasation, injection site necrosis, injection site reaction, skin disorder, skin reaction. Eligard dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

4896788-6 | Injection Site Abscess
on Jan 25, 2006 Male patient from UNITED STATES , 75 years of age, weighting 175.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Eligard (View Usage). Patient experienced the following unwanted or unexpected effects: injection site abscess. Eligard dosage: .

4887236-0 | Injection Site Necrosis
Patient was taking Eligard (View Usage). Patient had the following side effects: injection site necrosis on Jan 12, 2006 from CANADA Additional patient health information: Male patient , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Eligard dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).